Societal Economic Burden of Antibiotic Resistance in Uganda: A Cost of Illness Study
ABR poses a substantial societal burden that necessitates urgent and targeted gender-based interventions to prevent its escalation. These estimates may be used for future economic evaluation studies of ABR-mitigating interventions and to inform antimicrobial stewardship policies.
Authors
- Suzan Nakasendwa (ORCID: https://orcid.org/0000-0002-2655-4744)
- Reuben Kiggundu (ORCID: https://orcid.org/0000-0001-6141-9436)
- Joseph B. Babigumira (ORCID: https://orcid.org/0000-0003-3834-7141)
- Stephen Okoboi (ORCID: https://orcid.org/0000-0002-8738-0397)
- Ronald Galiwango (ORCID: https://orcid.org/0000-0002-5962-151X)
- Andrew Ddungu Kambugu (ORCID: https://orcid.org/0000-0002-3075-0211)
- Francis Kakooza (ORCID: https://orcid.org/0000-0003-4047-6620)
- Jonathan Mayito (ORCID: https://orcid.org/0000-0001-9611-2178)
- Conrad Tumwine (ORCID: https://orcid.org/0000-0002-1892-9665)
- Thorkild Tylleskär (ORCID: https://orcid.org/0000-0003-4801-4324)
- Ellon Twinomuhwezi
- Dathan M. Byonanebye (ORCID: https://orcid.org/0000-0001-9862-4724)
- Hope Mackline (ORCID: https://orcid.org/0000-0002-2593-8930)
- Lumbwe Chola (ORCID: https://orcid.org/0000-0001-6488-2813)
- Flavia Dhikusooka
- Vivian Twemanye (ORCID: https://orcid.org/0000-0002-0291-1604)
- Elly Nuwamanya (ORCID: https://orcid.org/0000-0001-6979-015X)
- Janet Nabisere
Institutions
- University of Bergen (NO)
- Makerere University (UG)
Publication Details
- Journal
- PharmacoEconomics - Open
- Published
- 2025-12-11
- DOI
- https://doi.org/10.1007/s41669-025-00625-8
- Primary Topic
- Antibiotic Use and Resistance
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Wellcome Trust